METHOTREXATE 50 MG/2 ML VIAL

Methotrexate
$3.3484per ML

Strength

25 mg/mL

Manufacturer

Hospira Inc.

NDC

61703016105

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

METHOTREXATE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA011719

On Market Since

11/4/2024

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price History

1W

0.0%

1M

-0.3%

3M

+1.0%

6M

+4.3%

1Y

+10.8%

3Y

N/A

5Y

N/A

All

+8.2%